HCPCS Code Descriptor:
Gefitinib, oral, 250 mg
Route of Administration:
IRESSA is a Oncology drug manufactured by ASTRAZENECA and administered via the Oral route of administration. The J Code: J8565 is aligned to the drug IRESSA.
IRESSA is a cancer medication that belongs to the class of drugs known as antineoplastic epidermal growth factor inhibitor. It works by slowing down and stopping the growth of cancer cells by blocking the epidermal growth factor protein. IRESSA is often used to treat certain types of lung cancer. This drug is manufactured by Astrazeneca and is aligned to the HCPCS code J8565. IRESSA has aligned to the HCPCS code since January 2015 and is still aligned to this code.